Why the study?
Stent length and stent overlap both worsen outcomes in percutaneous treatment of diffuse CAD, but comparative evidence between single very long stents and overlapping stents is scarce.
Does a single very long stent improve outcomes compared to overlapping stents in the treatment of diffuse coronary artery disease?
Does a single very long stent improve outcomes compared to overlapping stents in the treatment of diffuse coronary artery disease?
In the percutaneous treatment of diffuse coronary artery disease, using a single very long stent is associated with better clinical outcomes compared to using multiple overlapping stents.
Answers are grounded in this paper and cite their sources.
Overlapping stents may raise MACE risk in diffuse CAD; leaves open whether single long stents are superior pending RCTs.
BACKGROUND: Both stent length and stent overlap are associated with worse outcomes in the percutaneous treatment of diffuse coronary artery disease (dCAD). However, evidence comparing these issues is scarce. We aimed to compare the results between the use of single very long stent (VLS) and ≥2 overlapping stents (OS) in the treatment of dCAD. METHODS: Seven hundred twenty-four consecutive lesions were included: 275 treated with a single VLS (≥40 mm) and 449 with ≥2 OS. Procedural characteristics were assessed, and survival analysis was performed to compare the incidence of major adverse cardiovascular events (MACE; composite of cardiovascular death, nonfatal myocardial infarction, target lesion revascularization [TLR], or stent thrombosis) during a median follow-up of 31 months. The use of OS was an independent predictor of MACE. CONCLUSIONS: In this study, the use of VLS for the treatment of dCAD was associated with better outcomes compared to OS.
No takes yet. Share an insight, caveat, or question.
Negreira‐Caamaño et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: